A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

By sjmartinez • March 7, 2025

Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Feb 19;7(1):vdaf022. doi: 10.1093/noajnl/vdaf022. PMID: 40051661; PMCID: PMC11883343.

Tags: Cardiology/Epi, EGFR, FDG PET, Glioblastoma, imaging biomarker, molecular imaging, Osimertinib, Publications

Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF

Koay YC, McIntosh B, Ng YH, Cao Y, Wang X, Han Y, Tomita S, Bai AY, Hunter B, Misra A, Loughrey CM, Bannon PG, Lal[...]

The Spatial Transcriptional Activity of Hepatic TCF7L2 Regulates Zonated Metabolic Pathways that Contribute to Liver Fibrosis

Ayala I, Hebbale SK, Mononen J, Brearley-Sholto MC, Shannon CE, Valdez I, Fourcaudot M, Bakewell TM, Zagorska A, Romero G, Asmis M, Musa FA, Sily[...]

Pathways and Molecular Mechanisms Governing LDL Receptor Regulation

Schmidt HM, Jarrett KE, de Aguiar Vallim TQ, Tarling EJ. Pathways and Molecular Mechanisms Governing LDL Receptor Regulation. Circ Res. 2025 Apr 11;136(8):902-919. doi: 10.1161/CIRCRESAHA.124.323578.[...]